Genomic Medicine Market to Grow with Modernizing Agro-Industry During the Forecast Period
Sudden outbreak
of COVID-19 virus is driving the growth in Global Genomic Medicine Market in
the forecast period, 2022-2026.
According to TechSci Research report, “Global
Genomic
Medicine Market - Global Industry Size, Share, Trends, Opportunity and
Forecast, 2016-2026 Segmented By Application (Oncology, Cardiology,
Endocrinology, Rare Genetic Disorders, Others), By End User (Hospitals &
Clinics, Academic & Research Institutes, Others), By Region”, the global genomic medicine market would potentially project an
impressive growth in the forecast period, 2022-2026, with an impressive CAGR on
the account of increasing number of personalized medicine and their
availability for the treatment of the chronic diseases. Moreover, the rapidly
increasing number of chronic diseases is also driving the growth of the global
genomic medicine market in the upcoming five years. Additionally, growing
government support and increased number of genomic studies, steady decreased
cost for the genomic research and analysis are also supporting the growth of
the global genomic medicine market in the next five years. The global genomic
medicine market is geared to show exponential growth due to genetic
developments, and increased application of the same in various diseases.
Applications in bioengineering and synthetic biology is also substantiating the
growth of the market.
Genomic medicine or known as personal medicine are the pharmaceutical
drugs that are specifically designed with the genomic information from the DNA,
and protein profiling and their functionality meanwhile understanding their
interaction with the human health. These medicines have the ability to provide
the details of typical biological information of individual and thereby using
the information to design the respective patient’s treatment processes and
pharmaceutical drugs.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Genomic medicine Market"
https://www.techsciresearch.com/report/genomic-medicine-market/7805.html
The global genomic medicine market is segmented by
application, end user, competitive landscape, and regional distribution. Based
on end user, the market is further segmented into hospitals & clinics,
academic & research institutes, and others. Hospitals & clinics are
anticipated to hold the largest revenue shares of the market and dominate the
market segment on the account of the rapidly increasing number of the patients
suffering from chronic diseases and accessibility of the personalized medicine
for the patients. Additionally, increasing research funding by the government
to support the research institutes is further aiding the growth of the global
genomic medicine market in the next five years. Also, rapid use of genome
analysis for the treatment and early diagnosis of diseases is potentially
expected to substantiate the growth of the global genomic medicine market in
the future five years. Therefore, significant future growth can be experienced
by research institutes in the forecast years until 2026.
Based on application, the market is further
fragmented into oncology, cardiology, endocrinology, rare genetic disorders,
and others. Cardiology applications are anticipated to hold the significant
shares of the market and aid the growth of the market on the account of rising
instances of cardiovascular diseases. Moreover, the pandemic situation,
increased the number of patients suffering from pulmonary diseases,
cardiovascular issues, breathing problems etc. and thus driving the growth of
the global genomic medicine market in the next five years.
Genome Medical, Inc., BioMed Central Ltd, Aevi
Genomic Medicine, Inc., Congenica Ltd., Deep Genomics, Editas Medicine, Inc.,
Cleveland Clinic, are some of the market players holding the major shares of
the global genomic medicine market. Market players are actively involved in the
research and technological development in the product developments. The
advanced technology has made it possible for the industry to provide excellent
services through genomic medicine. Further advancement would aid the market
value and brand establishment in the future five years. New market players may
focus on the research and development to provide options that satisfies the
consumer demand as well as benefits the market players in building their brand
value. Other competitive strategies include mergers & acquisitions and new
product developments.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7805
Customers can also request for 10% free customization on this report.
“North America is
anticipated to hold the largest revenue shares in the future five years. The healthcare
industry is rapidly evolving advanced methods for the development of the
personalized medicine is further aiding the potential growth of the market. Countries
like United States and Canada have dedicated research facility toward genomic
studies and personalized pharmaceutical development. New market players must
focus on the research and technological advancement of the genomic medicine
such that rising consumer demands can be satisfied and this would aid their
brand establishment in the upcoming five years,” said Mr. Karan Chechi,
Research Director with TechSci Research, a research based Global management
consulting firm.
“Global Genomic Medicine
Market - Global Industry Size, Share, Trends, Opportunity and Forecast,
2016-2026 Segmented By Application (Oncology, Cardiology, Endocrinology, Rare
Genetic Disorders, Others), By End User (Hospitals & Clinics, Academic
& Research Institutes, Others), By Region”, has evaluated the
future growth potential of global genomic medicine and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global genomic medicine market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/